# Johnson & Johnson

> U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

**Wikidata**: [Q333718](https://www.wikidata.org/wiki/Q333718)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Johnson_&_Johnson)  
**Source**: https://4ort.xyz/entity/johnson-johnson

## Summary
Johnson & Johnson is a U.S. multinational corporation that manufactures medical devices, pharmaceuticals, and consumer packaged goods. Founded in 1886, it is one of the world's largest healthcare companies, with a diverse portfolio that includes well-known brands like Band-Aid, Neutrogena, and Listerine. The company operates as a public company, offering its securities on the New York Stock Exchange.

## Key Facts
- Founded in 1886 by Robert Wood Johnson I, Edward H. Johnson, and James Wood Johnson.
- Headquarters located in New Brunswick, New Jersey, United States.
- Publicly traded company with stock symbol JNJ on the New York Stock Exchange.
- Primary industries: medical devices, pharmaceuticals, and consumer packaged goods.
- Revenue figures: $70,074 million (2023), $82,059 million (2022), $81,581 million (2021).
- Net profit figures: $15,409 million (2023), $15,119 million (2022), $15,297 million (2021).
- Total assets: $133,411 million (2023), $157,728 million (2022), $174,894 million (2021).
- Employees: 136,400 (as of latest data).
- Subsidiaries: Janssen Biotech, Neutrogena, Listerine, Band-Aid, and others.
- Owned by: The Vanguard Group, BlackRock, and Kuwait Investment Authority.
- Part of: Dow Jones Industrial Average, S&P 500, and S&P 100 indices.
- Products: Medical devices, pharmaceuticals, and consumer packaged goods.
- Industry: Medical devices, pharmaceuticals, and consumer packaged goods.
- Revenue: $70,074 million (2023), $82,059 million (2022), $81,581 million (2021).
- Net income: $15,409 million (2023), $15,119 million (2022), $15,297 million (2021).
- Total assets: $133,411 million (2023), $157,728 million (2022), $174,894 million (2021).
- Employees: 136,400 (as of latest data).
- Headquarters: New Brunswick, New Jersey, United States.
- Country: United States.
- Website: https://www.jnj.com, http://www.jjmt.com.tw/, http://www.jnj.com.cn.
- Slogan: "Innovating for a healthier world."
- Founding date: January 1, 1886.
- Notable awards: National Medal of Technology and Innovation, Silver Anvil Award.
- Social media presence: Twitter (@jnj), Facebook (JNJNews), LinkedIn (JNJCareers), YouTube (JNJHistory).
- Wikipedia sitelinks: 50 (as of latest data).
- Wikidata description: U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer.

## FAQs
**What is Johnson & Johnson's primary business focus?**
Johnson & Johnson is a U.S. multinational corporation that focuses on medical devices, pharmaceuticals, and consumer packaged goods. It is one of the world's largest healthcare companies, with a diverse portfolio that includes well-known brands like Band-Aid, Neutrogena, and Listerine.

**Who founded Johnson & Johnson, and when was it founded?**
Johnson & Johnson was founded in 1886 by Robert Wood Johnson I, Edward H. Johnson, and James Wood Johnson. The company was established to provide medical devices, pharmaceuticals, and consumer packaged goods to the public.

**Where is Johnson & Johnson headquartered, and how many employees does it have?**
Johnson & Johnson is headquartered in New Brunswick, New Jersey, United States. As of the latest data, the company employs approximately 136,400 people.

**What are some of Johnson & Johnson's most famous products or services?**
Johnson & Johnson offers a range of products and services, including medical devices, pharmaceuticals, and consumer packaged goods. Some of its notable products include Band-Aid, Neutrogena, Listerine, and others.

**What is Johnson & Johnson's revenue and net profit?**
Johnson & Johnson's revenue for 2023 was $70,074 million, and its net profit was $15,409 million. The company's total assets were $133,411 million as of 2023.

**What companies own Johnson & Johnson?**
Johnson & Johnson is owned by public shareholders, including The Vanguard Group, BlackRock, and Kuwait Investment Authority. The company is a public company listed on the New York Stock Exchange.

**What are some of Johnson & Johnson's subsidiaries?**
Johnson & Johnson has several subsidiaries, including Janssen Biotech, Neutrogena, Listerine, Band-Aid, and others. These subsidiaries play a significant role in the company's operations and product offerings.

**What is Johnson & Johnson's stock ticker symbol?**
Johnson & Johnson's stock ticker symbol is JNJ, and it is listed on the New York Stock Exchange.

**What is Johnson & Johnson's slogan?**
Johnson & Johnson's slogan is "Innovating for a healthier world."

**What is Johnson & Johnson's website?**
Johnson & Johnson's official websites are https://www.jnj.com, http://www.jjmt.com.tw/, and http://www.jnj.com.cn.

## Why It Matters
Johnson & Johnson is a global leader in the healthcare industry, playing a crucial role in the well-being of individuals and communities worldwide. As a major player in the medical devices, pharmaceuticals, and consumer packaged goods sectors, it provides essential products and services that address a wide range of health needs. The company's influence extends to various aspects of public health, including the development of vaccines, medical devices, and consumer health products. Johnson & Johnson's commitment to innovation and technological advancements has led to significant breakthroughs in healthcare, improving the quality of life for millions of people. The company's global presence and extensive network of subsidiaries and partnerships contribute to its ability to meet the diverse needs of its clients and adapt to the evolving healthcare landscape. Overall, Johnson & Johnson's significance lies in its role as a key player in the global healthcare system, driving innovation and improving health outcomes through its diverse product offerings.

## Notable For
- Being one of the world's largest healthcare companies, with a diverse portfolio that includes medical devices, pharmaceuticals, and consumer packaged goods.
- Offering a wide range of products and services, including Band-Aid, Neutrogena, Listerine, and others.
- Having a strong global presence with headquarters in New Brunswick, New Jersey, United States.
- Being a public company listed on the New York Stock Exchange.
- Having a diverse and experienced leadership team, including CEO Alex Gorsky.
- Being owned by public shareholders, including The Vanguard Group, BlackRock, and Kuwait Investment Authority.
- Having a strong financial performance with significant revenue and net profit figures.
- Being a member of major stock market indices, including the Dow Jones Industrial Average, S&P 500, and S&P 100.
- Having a strong commitment to innovation and technological advancements, leading to significant breakthroughs in healthcare.
- Having a significant global impact and influence on the healthcare industry and public health.

## Body

### History and Founding
Johnson & Johnson was founded in 1886 by Robert Wood Johnson I, Edward H. Johnson, and James Wood Johnson. The company was established to provide medical devices, pharmaceuticals, and consumer packaged goods to the public. Johnson & Johnson's headquarters is located in New Brunswick, New Jersey, United States, reflecting its commitment to being a global leader in the healthcare industry.

### Corporate Structure and Leadership
Johnson & Johnson operates as a public company, offering its securities for sale to the general public. The company is listed on the New York Stock Exchange under the ticker symbol JNJ. Johnson & Johnson is owned by public shareholders, including The Vanguard Group, BlackRock, and Kuwait Investment Authority. The company's leadership team includes CEO Alex Gorsky, who has been with the company since 2018.

### Products and Services
Johnson & Johnson offers a wide range of products and services, including medical devices, pharmaceuticals, and consumer packaged goods. Some of the company's notable products include Band-Aid, Neutrogena, Listerine, and others. These products are designed to meet the diverse needs of individuals and communities worldwide, providing essential healthcare solutions.

### Financial Performance
Johnson & Johnson has a strong financial performance, with revenue of $70,074 million and net profit of $15,409 million in 2023. The company's total assets were $133,411 million as of 2023. These financial figures reflect Johnson & Johnson's position as a leading player in the healthcare industry and its ability to generate significant value for its shareholders.

### Global Presence and Operations
Johnson & Johnson has a strong global presence, with headquarters in New Brunswick, New Jersey, United States. The company operates in multiple countries and has a diverse network of subsidiaries and partnerships. Johnson & Johnson's global reach allows it to serve individuals and communities worldwide, providing essential healthcare solutions.

### Industry and Market Position
Johnson & Johnson operates in the medical devices, pharmaceuticals, and consumer packaged goods industries. The company's strong financial performance and global presence have positioned it as a leader in the healthcare industry. Johnson & Johnson's commitment to innovation and technological advancements has led to significant breakthroughs in healthcare, improving the quality of life for millions of people.

### Related Entities and Connections
Johnson & Johnson is connected to various related entities, including The Vanguard Group, BlackRock, and Kuwait Investment Authority. These entities have played a significant role in the company's history, operations, and success. The company's relationships with these entities reflect its commitment to innovation, global expansion, and meeting the diverse needs of its clients.

### Digital Presence and Media
Johnson & Johnson maintains a strong digital presence, with a website and various social media accounts. The company uses its digital platforms to engage with individuals and communities worldwide, promoting its products and services, and enhancing its brand image. Johnson & Johnson's digital presence has contributed to its global reach and market dominance.

### Awards and Recognition
Johnson & Johnson has received numerous awards and recognition for its contributions to the healthcare industry and its commitment to innovation and technological advancements. The company's achievements and contributions have been acknowledged and celebrated, further enhancing its reputation as a leader in the industry.

### Conclusion
Johnson & Johnson is a global leader in the healthcare industry, playing a crucial role in the well-being of individuals and communities worldwide. As a major player in the medical devices, pharmaceuticals, and consumer packaged goods sectors, it provides essential products and services that address a wide range of health needs. The company's influence extends to various aspects of public health, including the development of vaccines, medical devices, and consumer health products. Johnson & Johnson's commitment to innovation and technological advancements has led to significant breakthroughs in healthcare, improving the quality of life for millions of people. The company's global presence and extensive network of subsidiaries and partnerships contribute to its ability to meet the diverse needs of its clients and adapt to the evolving healthcare landscape. Overall, Johnson & Johnson's significance lies in its role as a key player in the global healthcare system, driving innovation and improving health outcomes through its diverse product offerings.

## References

1. Open Funder Registry
2. [Source](https://www.med-dept.com/resources/ww2-medical-equipment-manufacturers-and-suppliers/)
3. [Source](https://www.lobbyfacts.eu/datacard/johnson--johnson?rid=75617941310-89)
4. [proxy statement. 2021](https://johnsonandjohnson.gcs-web.com/node/47856/html#i27404618a04943f29d35a930342eab6e_82)
5. [Source](https://apps.prsa.org/Awards/SilverAnvil/Search?sakeyword=6BW-8313A42)
6. [Source](https://www.sec.gov/Archives/edgar/data/200406/000020040621000061/exhibit99.htm)
7. [Source](https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm)
8. International Standard Name Identifier
9. National Library of Portugal
10. Virtual International Authority File
11. [Source](https://www.cnbc.com/dow-30/)
12. [Source](https://www.ishares.com/us/products/239723/ishares-sp-100-etf)
13. Freebase Data Dumps. 2013
14. [Johnson&Johnson Annual Report 2020 10-K](https://johnsonandjohnson.gcs-web.com/node/47816/html)
15. Global LEI Index
16. [Source](http://km.aifb.kit.edu/services/crunchbase/)
17. [Source](https://www.sec.gov/Archives/edgar/data/200406/000020040616000071/form10-k20160103.htm)
18. [annual report](https://johnsonandjohnson.gcs-web.com/node/47816/html)
19. [Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/200406/000020040621000008/jnj-20210103.htm)
20. [Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/200406/000020040622000022/jnj-20220102.htm)
21. [Form 10-K. 2019](https://www.sec.gov/Archives/edgar/data/0000200406/000020040619000009/form10-k20181230.htm)
22. [Form 10-K. 2020](https://www.sec.gov/Archives/edgar/data/0000200406/000020040620000010/form10-k20191229.htm)
23. [Form 10-K. 2023](https://www.sec.gov/Archives/edgar/data/0000200406/000020040623000016/jnj-20230101.htm)
24. [Form 10-K. 2024](https://www.sec.gov/Archives/edgar/data/0000200406/000020040624000013/jnj-20231231.htm)
25. [Form 10-K. 2010](https://www.sec.gov/Archives/edgar/data/0000200406/000095012310019392/y80744e10vk.htm)
26. [Form 10-K. 2011](https://www.sec.gov/Archives/edgar/data/0000200406/000095012311018128/y86310ke10vk.htm)
27. [Form 10-K. 2012](https://www.sec.gov/Archives/edgar/data/0000200406/000119312512075565/d281803d10k.htm)
28. [Form 10-K. 2013](https://www.sec.gov/Archives/edgar/data/0000200406/000020040613000038/a2012123010-k.htm)
29. [Form 10-K. 2014](https://www.sec.gov/Archives/edgar/data/0000200406/000020040614000033/a2013122910-k.htm)
30. [Form 10-K. 2015](https://www.sec.gov/Archives/edgar/data/0000200406/000020040615000004/a2014122810-k.htm)
31. [Form 10-K. 2025](https://www.sec.gov/Archives/edgar/data/0000200406/000020040625000038/jnj-20241229.htm)
32. [Johnson & Johnson (JNJ) Stock Key Data](https://www.forbes.com/companies/johnson-johnson)
33. [Source](https://www.npr.org/2021/10/21/1047828535/baby-powder-cancer-johnson-johnson-bankruptcy)
34. [Form 10-K. 2016](https://www.sec.gov/Archives/edgar/data/0000200406/000020040616000071/form10-k20160103.htm)
35. [Form 10-K. 2017](https://www.sec.gov/Archives/edgar/data/0000200406/000020040617000006/form10-k20170101.htm)
36. GRID Release 2015-12-14
37. EU Transparency Register
38. [Source](https://www.sec.gov/Archives/edgar/data/0000200406/000020040621000011/jnjproxy2021.htm)
39. [Source](https://www.sec.gov/Archives/edgar/data/200406/000020040622000089/jnj-20221130.htm)
40. [Source](https://www.jnj.com/leadership/mary-c-beckerle)
41. [Form 8-K](https://www.sec.gov/Archives/edgar/data/200406/000020040615000028/a20150609form8-kbeckerle.htm)
42. [Source](https://www.jnj.com/leadership/d-scott-davis)
43. [Form 8-K](https://www.sec.gov/Archives/edgar/data/200406/000020040614000068/a201406198-kdscottdavis.htm)
44. [Source](https://www.jnj.com/leadership/ian-e-l-davis)
45. [Form 8-K](https://www.sec.gov/Archives/edgar/data/200406/000020040610000067/daviseightk.htm)
46. [Form 8-K](https://www.sec.gov/Archives/edgar/data/200406/000020040623000032/jnj-20230331.htm)
47. [Source](https://www.jnj.com/leadership/jennifer-a-doudna)
48. [proxy statement](https://www.sec.gov/Archives/edgar/data/200406/000020040618000009/a2018jnjproxy.htm#s0F7F1707681E553F94BAAA70AD77F885)
49. [Source](https://www.jnj.com/leadership/marillyn-a-hewson)
50. [proxy statement](https://www.sec.gov/Archives/edgar/data/200406/000020040619000013/a2019jnjproxy.htm#s5776D9A210025973BD9DA771DBC5C074)